The Effect of Monthly Anti-CD25(+) Treatment with Basiliximab on the Progression of Chronic Renal Dysfunction after Lung Transplantation

BACKGROUND: Chronic renal dysfunction (CRD), as predominantly related to calcineurin-inhibitor (CNI) nephrotoxicity, is associated with increased morbidity and mortality after lung transplantation (LTx). Basiliximab (BSX), a recombinant chimeric monoclonal antibody against CD25(+) on activated T-lym...

Descripción completa

Detalles Bibliográficos
Autores principales: Ross, D. J., Belperio, J., Natori, C., Ardehali, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Avicenna Organ Transplantation Institute 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471613/
https://www.ncbi.nlm.nih.gov/pubmed/32913585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471613/
https://www.ncbi.nlm.nih.gov/pubmed/32913585

Ejemplares similares